Centre issues guidelines for COVID management in children, discourages use of Remdesivir

New Delhi [India], June 10 : The Director General of Health Services (DGHC) under the Union Health Ministry on Wednesday issued guidelines for the management of COVID-19 in children below 18 years of age, according to which use of Remdesivir, an emergency use authorisation drug, has not been recommended and said that the usage of steroids in treating asymptomatic and mild cases of infection is harmful.
"Remdesivir, an emergency use authorisation drug, is not recommended in children. There is a lack of sufficient safety and efficacy data with respect to Remdesivir in children below 18 years of age," the guideline said.
"Steroids are not indicated and are harmful in asymptomatic and mild cases of COVID-19. It is indicated only in hospitalised moderately severe and critically ill COVID-19 cases under strict supervision. Steroids should be used at the right time, in the right dose, and for the right duration. Self-medication of steroids must be avoided," DGHC said in the guideline.
The guideline suggested only a rational usage of a high-resolution CT (HRCT) scan for knowing the extent and nature of lung involvement in COVID-19 positive patients.
"However, any additional information gained from HRCT scan of the chest often has little impact on treatment decisions, which are based almost entirely on clinical severity and physiological impairment. Therefore, treating physicians should be highly selective in ordering HRCT imaging of the chest in COVID-19 patients," it added.
The set of guidelines also suggested that children aged 5 years and under should not be required to wear masks.
"Children aged 5 years and under should not be required to wear masks. Children aged 6-11 years may wear a mask depending on the ability of the child to use a mask safely and appropriately under the direct supervision of parents/guardians. Children aged 12 years and over should wear a mask under the same conditions as adults," it said.